Enabling Graded and Large-Scale Multiplex of Desired Genes Using a Dual-Mode dCas9 Activator in Saccharomyces cerevisiae.

Standard approaches for dCas9-based modification of gene expression are limited in the ability to multiplex targets, establish streamlined cassettes, and utilize commonly studied Pol II promoters. In this work, we repurpose the dCas9-VPR activator to act as a dual-mode activator/repressor that can be programmed solely on the basis of target position at gene loci. Furthermore, we implement this approach using a streamlined Pol II-ribozyme system that allows expression of many sgRNAs from a single transcript. By "stepping" dCas9-VPR within the promoter region and ORF we create graded activation and repression (respectively) of target genes, allowing precise control over multiplexed gene modulation. Expression from the Pol II system increased the net amount of sgRNA production in cells by 3.88-fold relative to the Pol III SNR52 promoter, leading to a significant improvement in dCas9-VPR repression strength. Finally, we utilize our Pol II system to create galactose-inducible switching of gene expression states and multiplex constructs capable of modulating up to 4 native genes from a single vector. Our approach represents a significant step toward minimizing DNA required to assemble CRISPR systems in eukaryotes while enhancing the efficacy (greater repression strength), scale (more sgRNAs), and scope (inducibility) of dCas9-mediated gene regulation.

[1]  R. Müller,et al.  Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. , 1995, Gene.

[2]  Jens Boch,et al.  Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors , 2010, Proceedings of the National Academy of Sciences.

[3]  Ahmad S. Khalil,et al.  Synthetic biology: applications come of age , 2010, Nature Reviews Genetics.

[4]  Max A. Horlbeck,et al.  Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation , 2016, eLife.

[5]  F. Dietrich,et al.  Mapping of transcription start sites in Saccharomyces cerevisiae using 5′ SAGE , 2005, Nucleic acids research.

[6]  J. Keasling,et al.  Integrating Biological Redesign: Where Synthetic Biology Came From and Where It Needs to Go , 2014, Cell.

[7]  Ashty S. Karim,et al.  Cell‐Free Synthetic Systems for Metabolic Engineering and Biosynthetic Pathway Prototyping , 2016 .

[8]  W. Lim,et al.  Nucleosome breathing and remodeling constrain CRISPR-Cas9 function , 2016, eLife.

[9]  K. Sugiura,et al.  Development of a mono-promoter-driven CRISPR/Cas9 system in mammalian cells , 2015, Scientific Reports.

[10]  Hal S Alper,et al.  Short Synthetic Terminators for Improved Heterologous Gene Expression in Yeast. , 2015, ACS synthetic biology.

[11]  Jeffrey E. Barrick,et al.  Engineering reduced evolutionary potential for synthetic biology. , 2014, Molecular bioSystems.

[12]  R. Beerli,et al.  Engineering polydactyl zinc-finger transcription factors , 2002, Nature Biotechnology.

[13]  T. Lu,et al.  Tunable and Multifunctional Eukaryotic Transcription Factors Based on CRISPR/Cas , 2013, ACS synthetic biology.

[14]  Alexandro E. Trevino,et al.  Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.

[15]  T. S. Brown,et al.  Design of a highly reactive HDV ribozyme sequence uncovers facilitation of RNA folding by alternative pairings and physiological ionic strength. , 2004, Journal of molecular biology.

[16]  Max A. Horlbeck,et al.  Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation , 2014, Cell.

[17]  David Botstein,et al.  Synthetic biology tools for programming gene expression without nutritional perturbations in Saccharomyces cerevisiae , 2014, Nucleic acids research.

[18]  M. Teichmann,et al.  RNA polymerase III transcription control elements: themes and variations. , 2012, Gene.

[19]  S. Nakano,et al.  A role for upstream RNA structure in facilitating the catalytic fold of the genomic hepatitis delta virus ribozyme. , 2000, Journal of molecular biology.

[20]  Brian F. Pfleger,et al.  CRISPR interference as a titratable, trans-acting regulatory tool for metabolic engineering in the cyanobacterium Synechococcus sp. strain PCC 7002. , 2016, Metabolic engineering.

[21]  L. Nielsen,et al.  Quorum-sensing linked RNA interference for dynamic metabolic pathway control in Saccharomyces cerevisiae. , 2015, Metabolic engineering.

[22]  H. Alper,et al.  Systematic testing of enzyme perturbation sensitivities via graded dCas9 modulation in Saccharomyces cerevisiae. , 2017, Metabolic engineering.

[23]  J. Keasling,et al.  Design of a dynamic sensor-regulator system for production of chemicals and fuels derived from fatty acids , 2012, Nature Biotechnology.

[24]  Yunde Zhao,et al.  Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro and in vivo for CRISPR-mediated genome editing. , 2014, Journal of integrative plant biology.

[25]  Keith E. J. Tyo,et al.  A Glucose-Sensing Toggle Switch for Autonomous, High Productivity Genetic Control. , 2017, ACS synthetic biology.

[26]  Luke A. Gilbert,et al.  CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.

[27]  Jennifer A. Doudna,et al.  Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering , 2016, Cell.

[28]  Huimin Zhao,et al.  Homology-integrated CRISPR-Cas (HI-CRISPR) system for one-step multigene disruption in Saccharomyces cerevisiae. , 2015, ACS synthetic biology.

[29]  David R. McMillen,et al.  Design and characterization of a dual-mode promoter with activation and repression capability for tuning gene expression in yeast , 2014, Nucleic acids research.

[30]  Ricardo Flores,et al.  Peripheral regions of natural hammerhead ribozymes greatly increase their self‐cleavage activity , 2003, The EMBO journal.

[31]  Robert J Linhardt,et al.  CRISPathBrick: Modular Combinatorial Assembly of Type II-A CRISPR Arrays for dCas9-Mediated Multiplex Transcriptional Repression in E. coli. , 2015, ACS synthetic biology.

[32]  Jay D Keasling,et al.  Multiplex metabolic pathway engineering using CRISPR/Cas9 in Saccharomyces cerevisiae. , 2015, Metabolic engineering.

[33]  J. Keasling,et al.  High-level semi-synthetic production of the potent antimalarial artemisinin , 2013, Nature.

[34]  A. Carbonell,et al.  Trans-cleaving hammerhead ribozymes with tertiary stabilizing motifs: in vitro and in vivo activity against a structured viroid RNA , 2010, Nucleic acids research.

[35]  Matthew Deaner,et al.  Promoter and Terminator Discovery and Engineering. , 2016, Advances in biochemical engineering/biotechnology.

[36]  Rishi Garg,et al.  Controlling promoter strength and regulation in Saccharomyces cerevisiae using synthetic hybrid promoters , 2012, Biotechnology and bioengineering.

[37]  James M. Carothers,et al.  Digital logic circuits in yeast with CRISPR-dCas9 NOR gates , 2017, Nature Communications.

[38]  G. Bellí,et al.  An activator/repressor dual system allows tight tetracycline-regulated gene expression in budding yeast. , 1998, Nucleic acids research.

[39]  N. Perrimon,et al.  Highly-efficient Cas9-mediated transcriptional programming , 2015, Nature Methods.

[40]  Daniel Segrè,et al.  Epistatic Interaction Maps Relative to Multiple Metabolic Phenotypes , 2011, PLoS genetics.

[41]  Monica P. McNerney,et al.  Precise metabolic engineering of carotenoid biosynthesis in Escherichia coli towards a low-cost biosensor. , 2015, Metabolic engineering.

[42]  Jeongbin Park,et al.  CRISPR/Cas9-mediated gene knockout screens and target identification via whole-genome sequencing uncover host genes required for picornavirus infection , 2017, The Journal of Biological Chemistry.

[43]  J. Xu,et al.  Empower multiplex cell and tissue-specific CRISPR-mediated gene manipulation with self-cleaving ribozymes and tRNA , 2016, Nucleic acids research.

[44]  Sundari Suresh,et al.  Quantitative CRISPR interference screens in yeast identify chemical-genetic interactions and new rules for guide RNA design , 2016, Genome Biology.

[45]  Luke A. Gilbert,et al.  Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds , 2015, Cell.

[46]  E. Lander,et al.  Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.

[47]  G. Stephanopoulos,et al.  Improving fatty acids production by engineering dynamic pathway regulation and metabolic control , 2014, Proceedings of the National Academy of Sciences.

[48]  O. Harismendy,et al.  A Minimal Promoter for TFIIIC-dependent in Vitro Transcription of snoRNA and tRNA Genes by RNA Polymerase III* , 2006, Journal of Biological Chemistry.

[49]  R. Linhardt,et al.  Rapid generation of CRISPR/dCas9-regulated, orthogonally repressible hybrid T7-lac promoters for modular, tuneable control of metabolic pathway fluxes in Escherichia coli , 2016, Nucleic acids research.

[50]  Jay D Keasling,et al.  System-level perturbations of cell metabolism using CRISPR/Cas9. , 2017, Current opinion in biotechnology.

[51]  Kristin R Brogaard,et al.  A base pair resolution map of nucleosome positions in yeast , 2012, Nature.

[52]  Guoqiang Chen,et al.  CRISPRi engineering E. coli for morphology diversification. , 2016, Metabolic engineering.

[53]  Tom Ellis,et al.  Rational Diversification of a Promoter Providing Fine-Tuned Expression and Orthogonal Regulation for Synthetic Biology , 2012, PloS one.

[54]  Zachary N. Russ,et al.  An enzyme-coupled biosensor enables (S)-reticuline production in yeast from glucose. , 2015, Nature chemical biology.